61.   Instead, the FDA would require the company to warn patients about potential dangers before they took Accolate.

62.   Investors are concerned that the fuel for higher share prices is drying up as more companies warn that earnings may not grow as fast as previously expected.

63.   Its operating costs were higher than expected, however, and the company warned that severe winter weather in the U.S. caused a reduction in January passenger traffic.

64.   Last March, the company warned of an earnings slowdown, noting that profits should improve in the second half of the year.

65.   Last month, the company warned financial analysts to expect lower sales, because the delay in setting a standard was preventing many consumers from buying.

66.   Last week, the company warned that the decline in new orders was eroding its profit margin.

67.   Last week, the company warned investors that the decline in new orders was eroding its profit margin.

68.   Late Thursday, the Islandia, New York-based company warned third-quarter sales will lag estimates because of poor European revenue.

69.   Likewise, financial companies have warned that they will suffer as consumers and investors spend, borrow, and invest less.

70.   Last month, the company warned of possible delays in delivering faster audio and video chips.